Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Rachel Passow"'
Autor:
Justin Hwang, Xiaolei Shi, Andrew Elliott, Taylor E. Arnoff, Julie McGrath, Joanne Xiu, Phillip Walker, Hannah E. Bergom, Abderrahman Day, Shihab Ahmed, Sydney Tape, Allison Makovec, Atef Ali, Rami M. Shaker, Eamon Toye, Rachel Passow, John R. Lozada, Jinhua Wang, Emil Lou, Kent W. Mouw, Benedito A. Carneiro, Elisabeth I. Heath, Rana R. McKay, W. Michael Korn, Chadi Nabhan, Charles J. Ryan, Emmanuel S. Antonarakis
Publikováno v:
Clinical Cancer Research. :OF1-OF12
Purpose: In patients with metastatic prostate cancer (mPC), ATM and BRCA2 mutations dictate differences in PARPi inhibitor response and other therapies. We interrogated the molecular features of ATM- and BRCA2-mutated mPC to explain the divergent cli
Autor:
Emmanuel S. Antonarakis, Charles J. Ryan, Chadi Nabhan, W. Michael Korn, Rana R. McKay, Elisabeth I. Heath, Benedito A. Carneiro, Kent W. Mouw, Emil Lou, Jinhua Wang, John R. Lozada, Rachel Passow, Eamon Toye, Rami M. Shaker, Atef Ali, Allison Makovec, Sydney Tape, Shihab Ahmed, Abderrahman Day, Hannah E. Bergom, Phillip Walker, Joanne Xiu, Julie McGrath, Taylor E. Arnoff, Andrew Elliott, Xiaolei Shi, Justin Hwang
Tumor mutation burden (muts/Mb) of ATM and BRCA2 mutant mPCs.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::191c373d6a50da609d3a46c138118bcf
https://doi.org/10.1158/1078-0432.23223082.v1
https://doi.org/10.1158/1078-0432.23223082.v1
Autor:
Emmanuel S. Antonarakis, Charles J. Ryan, Chadi Nabhan, W. Michael Korn, Rana R. McKay, Elisabeth I. Heath, Benedito A. Carneiro, Kent W. Mouw, Emil Lou, Jinhua Wang, John R. Lozada, Rachel Passow, Eamon Toye, Rami M. Shaker, Atef Ali, Allison Makovec, Sydney Tape, Shihab Ahmed, Abderrahman Day, Hannah E. Bergom, Phillip Walker, Joanne Xiu, Julie McGrath, Taylor E. Arnoff, Andrew Elliott, Xiaolei Shi, Justin Hwang
Comparisons of WTS profiles between ATMm and BRCA2m to the HRP group.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa835232fab1fe3d96613aa47ba9d13c
https://doi.org/10.1158/1078-0432.23223070
https://doi.org/10.1158/1078-0432.23223070
Autor:
Emmanuel S. Antonarakis, Charles J. Ryan, Chadi Nabhan, W. Michael Korn, Rana R. McKay, Elisabeth I. Heath, Benedito A. Carneiro, Kent W. Mouw, Emil Lou, Jinhua Wang, John R. Lozada, Rachel Passow, Eamon Toye, Rami M. Shaker, Atef Ali, Allison Makovec, Sydney Tape, Shihab Ahmed, Abderrahman Day, Hannah E. Bergom, Phillip Walker, Joanne Xiu, Julie McGrath, Taylor E. Arnoff, Andrew Elliott, Xiaolei Shi, Justin Hwang
AR activities and NEPC signatures in ATM- and BRCA2- mutated tumors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78a2547e0dff08e1a7d077b05aaab062
https://doi.org/10.1158/1078-0432.23223079
https://doi.org/10.1158/1078-0432.23223079
Autor:
Emmanuel S. Antonarakis, Charles J. Ryan, Chadi Nabhan, W. Michael Korn, Rana R. McKay, Elisabeth I. Heath, Benedito A. Carneiro, Kent W. Mouw, Emil Lou, Jinhua Wang, John R. Lozada, Rachel Passow, Eamon Toye, Rami M. Shaker, Atef Ali, Allison Makovec, Sydney Tape, Shihab Ahmed, Abderrahman Day, Hannah E. Bergom, Phillip Walker, Joanne Xiu, Julie McGrath, Taylor E. Arnoff, Andrew Elliott, Xiaolei Shi, Justin Hwang
Overall survival of ATM, BRCA2 mutant, and HRDother mPCs.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c421438fae6b70ae644cf1f1e3e5635
https://doi.org/10.1158/1078-0432.23223085.v1
https://doi.org/10.1158/1078-0432.23223085.v1
Autor:
Emmanuel S. Antonarakis, Charles J. Ryan, Chadi Nabhan, W. Michael Korn, Rana R. McKay, Elisabeth I. Heath, Benedito A. Carneiro, Kent W. Mouw, Emil Lou, Jinhua Wang, John R. Lozada, Rachel Passow, Eamon Toye, Rami M. Shaker, Atef Ali, Allison Makovec, Sydney Tape, Shihab Ahmed, Abderrahman Day, Hannah E. Bergom, Phillip Walker, Joanne Xiu, Julie McGrath, Taylor E. Arnoff, Andrew Elliott, Xiaolei Shi, Justin Hwang
Composition and rates of all detectable genomic features detectable through the Caris diagnostic platform.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8aa038512c745dc2718e9411994a3455
https://doi.org/10.1158/1078-0432.23223076
https://doi.org/10.1158/1078-0432.23223076
Autor:
Emmanuel S. Antonarakis, Charles J. Ryan, Chadi Nabhan, W. Michael Korn, Rana R. McKay, Elisabeth I. Heath, Benedito A. Carneiro, Kent W. Mouw, Emil Lou, Jinhua Wang, John R. Lozada, Rachel Passow, Eamon Toye, Rami M. Shaker, Atef Ali, Allison Makovec, Sydney Tape, Shihab Ahmed, Abderrahman Day, Hannah E. Bergom, Phillip Walker, Joanne Xiu, Julie McGrath, Taylor E. Arnoff, Andrew Elliott, Xiaolei Shi, Justin Hwang
Purpose:In patients with metastatic prostate cancer (mPC), ATM and BRCA2 mutations dictate differences in PARPi inhibitor response and other therapies. We interrogated the molecular features of ATM- and BRCA2-mutated mPC to explain the divergent clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fd66e3997d8877977f0ae0dd35ad49b
https://doi.org/10.1158/1078-0432.c.6666733
https://doi.org/10.1158/1078-0432.c.6666733